The IPSOS trial - report from ESMO2022

from Medical Digest & Congress Report · host Medical Congress News

Siow Ming Lee, Professor of Medical Oncology at University College London, presented the results of the IPSOS trial at the ESMO 2022 Congress. This was a phase 3 study evaluating first-line atezolizumab vs. single agent chemotherapy in NSCLC patients not eligible for a platinum-based regimen. Video: https://congressreport.eu/scientific-contents/interview:ipsos-trial

Episode metadata supplied by the publisher feed · Published Sep 23, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

The IPSOS trial - report from ESMO2022

0:00 6:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 23, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!